Page 109 - Read Online

Page 18 of 18 Alqahtani et al. Hepatoma Res 2020;6:58 I http://dx.doi.org/10.20517/2394-5079.2020.49

Gastroenterol 2005;14:329-35.
156. Buti M, Homs M, Rodriguez-Frias F, Funalleras G, Jardí R, et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-
term follow-up study. J Viral Hepat 2011;18:434-42.
157. Béguelin C, Moradpour D, Sahli R, Suter-Riniker F, Lüthi A, et al; Swiss HIV Cohort Study. Hepatitis delta-associated mortality in HIV/
HBV-coinfected patients. J Hepatol 2017;66:297-303.
158. Yurdaydin C. Treatment of chronic delta hepatitis. Semin Liver Dis 2012;32:237-44.
159. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, et al; HIDIT Study Group. Peginterferon plus adefovir versus either
drug alone for hepatitis delta. N Engl J Med 2011;364:322-31.
160. Kabaçam G, Dalekos GN, Çakaloğlu Y, Zachou K, Bock T, et al. Pegylated interferon-based treatment in patients with advanced liver
disease due to chronic delta hepatitis. Turk J Gastroenterol 2012;23:560-8.
161. Heller T, Rotman Y, Koh C, Clark S, Haynes-Williams V, et al. Long-term therapy of chronic delta hepatitis with peginterferon alfa.
Aliment Pharmacol Ther 2014;40:93-104.
162. Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D:
regression of advanced hepatic fibrosis. Gastroenterology 2004;126:1740-9.
163. Heidrich B, Yurdaydın C, Kabaçam G, Ratsch BA, Zachou K, et al; HIDIT-1 Study Group. Late HDV RNA relapse after peginterferon
alpha-based therapy of chronic hepatitis delta. Hepatology 2014;60:87-97.